rs121907970
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4BP6_Very_Strong
The NM_000520.6(HEXA):c.739C>T(p.Arg247Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00278 in 1,614,084 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,other (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R247Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000520.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HEXA | NM_000520.6 | c.739C>T | p.Arg247Trp | missense_variant | 7/14 | ENST00000268097.10 | |
HEXA | NM_001318825.2 | c.772C>T | p.Arg258Trp | missense_variant | 7/14 | ||
HEXA | NR_134869.3 | n.781C>T | non_coding_transcript_exon_variant | 7/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HEXA | ENST00000268097.10 | c.739C>T | p.Arg247Trp | missense_variant | 7/14 | 1 | NM_000520.6 | P1 | |
ENST00000570175.1 | n.1938G>A | non_coding_transcript_exon_variant | 3/3 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00177 AC: 270AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00154 AC: 387AN: 251482Hom.: 1 AF XY: 0.00163 AC XY: 221AN XY: 135920
GnomAD4 exome AF: 0.00289 AC: 4220AN: 1461776Hom.: 7 Cov.: 31 AF XY: 0.00283 AC XY: 2057AN XY: 727196
GnomAD4 genome ? AF: 0.00177 AC: 270AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.00154 AC XY: 115AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3Other:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 04, 2018 | This variant is associated with the following publications: (PMID: 31692161, 29482223, 26990548, 19858779, 22975760, 1384323, 17259242, 9169471) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | HEXA: PP3, BS2 - |
other, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 01, 2016 | - Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles). |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Aug 26, 2022 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 27, 2021 | Variant summary: HEXA c.739C>T (p.Arg247Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 251482 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is slight higher than the estimated maximal expected allele frequency for a pathogenic variant in HEXA causing Tay-Sachs Disease phenotype (0.0014). About 35% of non-Jewish individuals identified as heterozygotes by HEX A enzyme-based testing are carriers of a pseudodeficiency allele. About 2% of Jewish individuals identified as heterozygotes by HEX A enzyme-based testing in carrier screening programs are actually heterozygous for the variant of interest. c.739C>T is widely accepted in the field as benign pseudodeficient allele. c.739C>T has been reported in the literature in individuals affected with Tay-Sachs Disease. These reports do not provide unequivocal conclusions about association of the variant with Tay-Sachs Disease. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Cao_1997). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as benign, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. - |
Beta-hexosaminidase a, pseudodeficiency of Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 1993 | - - |
Tay-Sachs disease Other:1
other, criteria provided, single submitter | clinical testing | Invitae | May 08, 2017 | - pseudodeficiency allele |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at